Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Grunenthal

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ divests European rights for cholesterol med Crestor to Grünenthal

It will also continue to manufacture and supply Crestor to Grünenthal during the transition period. ... AZ. “Grünenthal previously acquired the rights to several established AstraZeneca medicines and is well placed to ensure continued access to

Big Pharma, Little Pharma

Big Pharma, Little Pharma to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

Gilead and ViiV among winners at PM Society Digital Awards

Gilead and ViiV among winners at PM Society Digital Awards Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well. .

Europe's public-private alliance targets pain management

Europe's public-private alliance targets pain management an effort led by Winfried Meissner of the University of Jena and Hiltrud Liedgens of drugmaker Grünenthal.

Pharma's first 'performance marketing' agency launched

Pharma's first 'performance marketing' agency launched Prior to that he spent a decade in pharma, first at Sanofi and then Grünenthal, rising to senior marketing manager at the latter before moving agency-side.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Visformatics (VISFO)

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....